| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| CEFTAROLINE (has an active metabolite)
| CEFTAROLINE | ANTIINFECTIVE | INTRAVENOUS | Cmax 27.7 MICROMOLAR (600 MILLIGRAM) VD 19.9 LITER (600 MILLIGRAM) PPB 20 PERCENT Cl 9.58 LITER / HOUR (600 MILLIGRAM) HT 1.6 HOUR (600 MILLIGRAM) SOLUBILITY WATER SOLUBLE PRODRUG OF CEFTAROLINE | PENICILLIN-BINDING PROTEIN 1B PENICILLIN-BINDING PROTEIN 1A PENICILLIN-BINDING PROTEIN 2A | BACTERIAL PENICILLIN-BINDING PROTEIN INHIBITOR CHEMBL2354204 BACTERIAL PENICILLIN-BINDING PROTEIN P02918 PENICILLIN-BINDING PROTEIN 1A BACTERIA ENZYME PROTEASE SERINE UNCLASSIFIED | ANSM (in French) | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M CEFTAROLINE (is an active metabolite)
| CEFTAROLINE | ANTIINFECTIVE | - | PENICILLIN-BINDING PROTEIN 1B PENICILLIN-BINDING PROTEIN 1A PENICILLIN-BINDING PROTEIN 2A PDB 3ZG0 (CRYSTAL STRUCTURE OF CEFTAROLINE ACYL-PBP2A FROM MRSA WITH NON- COVALENTLY BOUND CEFTAROLINE AND MURAMIC ACID AT ALLOSTERIC SITE OBTAINED BY COCRYSTALLIZATION) LIGAND CODE = 1W8 (link to the list of PDB complexes) Download experimental 3D coordinates of 1W8 with added hydrogens | BACTERIAL PENICILLIN-BINDING PROTEIN INHIBITOR CHEMBL2354204 BACTERIAL PENICILLIN-BINDING PROTEIN P02918 PENICILLIN-BINDING PROTEIN 1A BACTERIA ENZYME PROTEASE SERINE UNCLASSIFIED | ANSM (in French) | ||||
